No image available for this title

LITERATURE

Clinical Safety and Efficacy of Clopidogrel-Implications of the Clopidogrel versus Aspirin in Patients at Risk of Ischemic Events (CAPRIE) Study for Future Management of Atherosclerotic Disease


Clopidogrel is a new antiplatelet agent that has recently been approved in the United States for the reduction of atherosclerotic
events (myocardial infarction, stroke, and vascular death) in patients with atherosclerosis documented by recent
stroke, recent myocardial infarction, or established peripheral arterial disease (PAD).


Availability

Vaclo-002Titan CenterAvailable

Detail Information

Series Title
-
Call Number
-
Publisher : .,
Collation
-
Language
English
ISBN/ISSN
-
Classification
NONE
Content Type
-
Media Type
-
Carrier Type
-
Edition
-
Subject(s)
Specific Detail Info
CLINICAL THERAPEVMCSVVOL. 20, SUPPLEMENT B, 1998
Statement of Responsibility

Other version/related

No other version available


File Attachment



Information


RECORD DETAIL


Back To Previous